Engineered AuNPs/fMWCNT Nanocomposite Electrodes for High‐Sensitivity Methylglyoxal Sensing in Saliva and Sweat for Non‐Invasive Diabetes Monitoring Authors: Ahadul Amin Soshi, Md Younus Ali, Dadbeh Pazuki, Matiar M.R. Howlader Published: 2026 ABSTRACT ABSTRACTElevated methylglyoxal (MG) levels contribute to diabetes‐related complications through accelerated formation of advanced glycation end products, highlighting the need for sensitive, portable, and non‐invasive monitoring strategies. Here, we report a gold–carbon nanohybrid electrochemical MG sensor integrated into a three‐dimensional printed microfluidic platform for point‐of‐care analysis. The sensing interface is engineered by sequential electrodeposition of carboxyl‐functionalized multi‐walled carbon nanotubes (fMWCNT) and gold nanoparticles (AuNPs) onto a screen‐printed carbon electrode (SPCE). The fMWCNT provide a high‐surface‐area scaffold for MG adsorption, while AuNPs enhance electroactive surface area and electron transfer. The AuNPs/fMWCNT/SPCE sensor exhibits quasi‐reversible electrochemical behavior suitable for sensitive MG detection. The optimized sensor achieves reliable MG detection across a wide dynamic range (50 nM–100 µM), with limits of detection of 40 nM in aqueous media and 400 nM in artificial sweat. Accurate MG quantification in human saliva and sweat, with recoveries exceeding 97%, demonstrates robustness in complex biological matrices. This work demonstrates the potential of this electrochemical sensing system for future wearable biosensors and personalized diabetes monitoring. Introduction Methylglyoxal (MG), a highly reactive byproduct of glycolysis, acts as a major precursor of advanced glycation end products (AGEs) [1]. These AGEs contribute to the molecular pathogenesis and progression of diabetes and its associated complications, including nephropathy, retinopathy, neuropathy [2], and cardiovascular disease [3], through oxidative stress, inflammation, and impairment of insulin secretion [4, 5, 6]. Clinical evidence indicates that MG concentrations in plasma are typically in the submicromolar range in healthy individuals, whereas significantly elevated levels (2.8–8.4 µM) are observed in patients with diabetes [7]. MG also serves as a key biomarker, with salivary levels in diabetes (1.32–1.42 µM) being significantly higher than in healthy subjects (0.19–0.26 µM), while sweat concentrations in healthy individuals range from 0.28 to 0.78 µM [8, 9]. The rising global prevalence of diabetes—projected to reach 700 million by 2045 and affecting 11% of Canadian adults—highlights the urgent need for sensitive, non‐invasive platforms capable of monitoring physiological MG levels across multiple biofluids for early diagnosis and management [10, 11]. A range of analytical techniques has been developed for quantitative MG determination in biological matrices. While conventional laboratory methods such as chromatography and electrophoresis provide high accuracy for MG detection, their reliance on complex sample preparation, chemical derivatization, and expensive, bulky instrumentation limits their use in point‐of‐care (PoC) settings [12, 13, 14, 15]. In contrast, electrochemical sensors offer a more practical alternative due to their rapid response, high sensitivity, and potential for miniaturization [16]. Within this field, enzymatic sensors employing glyoxalase‐1 provide high selectivity and low detection limits but suffer from enzyme instability, environmental sensitivity, short operational lifetimes, narrow linear ranges, and high fabrication and storage costs [17, 18, 19]. Consequently, increasing interest has shifted toward non‐enzymatic electrochemical sensors, which rely on direct electrocatalytic oxidation or adsorption of MG at functional electrode interfaces. These platforms offer superior chemical and thermal stability, simpler fabrication, wider dynamic ranges, and enhanced suitability for long‐term real‐time monitoring, making them attractive candidates for PoC diabetes diagnostics and wearable sensing technologies [20]. Despite these advancements, several challenges remain with respect to sensitivity, physiological relevance, and validation in non‐invasive biofluids for reported non‐enzymatic MG sensors (Table S9). Early carbon nanotube‐based systems, such as single‐walled carbon nanotube (SWCNT) electrodes, demonstrated broad detection ranges but comparatively modest sensitivity [21], while metal‐oxide composites such as V2O5 exhibited limited sensitivity at low MG concentrations due to slow electron‐transfer kinetics arising from polaron hopping and the wide bandgap of the semiconductor [22, 23, 24]. Validation in non‐invasive biofluids remains limited. For instance, CuO–Au and PANI–NiO systems evaluated in urine and saliva have demonstrated limited sensitivity and operational stability due to material instability and limited response [25, 26, 27, 28]. Furthermore, common fabrication methods such as drop‐casting can lead to nanoparticle agglomeration, non‐uniform film formation, and variable interfacial contact, potentially resulting in suboptimal reproducibility and compromised electrochemical performance [29]. Even electrodeposited multi‐walled carbon nanotube (MWCNT)‐based architectures have often been validated only at relatively high MG concentrations or in simplified matrices, with limited evaluation under physiologically relevant conditions in non‐invasive biofluids [30, 31]. Collectively, these findings suggest that reported performance differences arise not only from material selection but also from variations in interfacial structure, charge‐transfer kinetics, and analytical validation strategies. Beyond material composition and fabrication, important gaps persist in understanding MG electrochemistry at solid–liquid interfaces, particularly with respect to reaction kinetics, reversibility and interference from dissolved oxygen. Most studies classify MG redox behavior only as qualitatively irreversible or quasi‐reversible [32, 33, 34, 35], without comprehensive evaluation based on peak separation, scan‐rate dependence, and kinetic parameter extraction. Furthermore, despite the proximity of the oxygen reduction reaction potential to the cathodic peak of MG, few studies have systematically investigated the influence of dissolved oxygen on the MG reduction process, although several studies have evaluated its general electrochemical reduction mechanism. As a result, direct comparison across different sensing platforms can be challenging, and the relationship between electron‐transfer behavior and analytical performance is not always clearly established. Nevertheless, many reported MG sensors rely on single‐material architectures fabricated via drop‐casting or simple electrodeposition, while hybrid interfaces offering complementary catalytic functionality, improved film uniformity, and enhanced reproducibility have received comparatively less attention. In addition, continued reliance on rigid glassy carbon electrodes—often requiring external reference and counter electrodes—can complicate miniaturization and integration into portable or wearable sensing formats. Collectively, these limitations highlight the need for mechanistically informed hybrid‐material electrode platforms capable of providing highly sensitive and electrochemically stable MG detection in non‐invasive biofluids for PoC diabetes diagnostics. To address these limitations, we developed an integrated electrochemical sensing platform that combines hybrid nanocomposite engineering, electrochemical analysis, and microfluidic integration. The platform comprises a sequentially electrodeposited AuNPs/fMWCNT nanocomposite on a screen‐printed carbon electrode (SPCE), integrated with a dual‐inlet polydimethylsiloxane (PDMS) microfluidic module supported by a polylactic acid (PLA) framework (Figure 1a,b). Sequential electrodeposition yields uniform and mechanically robust binder‐free nanocomposite films with low charge‐transfer resistance, mitigating agglomeration and delamination associated with drop‐cast electrodes [34]. Functionalized MWCNTs provide a conductive network and facilitate MG preconcentration through hydrogen bonding and dipole–dipole interactions. Electrodeposited AuNPs further increase the electroactive surface area and improve MG electrochemical response. The pump‐free PDMS microfluidic design enables controlled analyte–electrolyte contact at low sample volumes using laminar flow; however, its mechanical compliance requires external structural reinforcement. A rigid PLA frame secures the PDMS layers using a screw‐and‐nut assembly, enabling reproducible electrode alignment and airtight sealing [36]. This modular, disassemblable enclosure ensures mechanical stability and consistent electrochemical performance during repeated use. Overall, this cost‐effective platform provides highly sensitive and reproducible MG detection in saliva and sweat, supporting decentralized, non‐invasive diabetes monitoring and PoC diagnostics. (a) Schematic illustration of AuNPs/fMWCNT/SPCE fabrication and (b) microfluidic device for non‐invasive MG detection. SWV responses: (c) bare SPCE with MG, (d) modified electrodes without MG, (e) modified electrodes with MG, and (f) AuNPs/fMWCNT modified electrodes with MG compared to blank solution, illustrating the role of electrode materials in MG detection. Results and Discussion Role of Materials in Electrochemical Sensing of MG The electrochemical detection of MG is governed by interactions between its carbonyl functional groups and catalytically active sites at the electrode‐electrolyte interface. MG is a highly reactive α‐dicarbonyl compound containing both aldehyde and ketone functional groups, which contribute differently to its electrochemical behavior [37]. The aldehyde carbonyl is generally more reactive than the ketone carbonyl due to lower steric hindrance and higher electrophilicity, bearing a hydrogen substituent rather than bulkier alkyl groups [38]. As a result, nucleophilic attack and electron transfer preferentially occur at the aldehyde group, favoring electrochemical reduction under aqueous conditions (Figure 1a) [39]. The AuNPs/fMWCNT‐modified SPCE exhibited well‐defined oxidation and reduction peaks, with a significantly higher cathodic current than anodic current (Figure S1), indicating reduction‐dominated MG sensing. This behavior reflects the synergistic catalytic role of the nanocomposite: fMWCNT provide a conductive π‐electron network and functional groups for MG adsorption [40], while AuNPs enhance heterogeneous electron‐transfer kinetics by lowering the activation energy for MG reduction [41]. The layered nanocomposite architecture further improves charge‐transfer efficiency by reducing interfacial resistance and increasing the density of accessible electroactive sites [42, 43]. Accordingly, subsequent analyses focus on MG reduction. The peak‐to‐peak separation (ΔEp ≈ 70 mV) slightly exceeds the theoretical 59 mV for a reversible one‐electron process, indicating quasi‐reversible MG electrochemical behavior at the AuNPs/fMWCNT/SPCE interface [44, 45]. This modest deviation from ideal Nernstian behavior arises from kinetically limited electron transfer under mixed diffusion‐adsorption control, consistent with prior reports [25, 44, 45]. In contrast, many CNT‐based and organic–inorganic nanohybrid MG sensors exhibit predominantly irreversible oxidation, often attributed to the absence of catalytically active metallic components such as AuNPs [21, 26, 34]. Although CNTs and metal oxides (e.g., NiO) enhance surface area and conductivity, they largely act as passive scaffolds with limited facilitation of interfacial electron transfer. The lack of an effective metallic mediator leads to sluggish, asymmetric charge transport, higher overpotentials, reduced peak currents, and progressive surface fouling, ultimately limiting sensitivity and operational stability [46]. A detailed analysis of the quasi‐reversible MG redox mechanism is provided in Section 2.3. Control experiments were conducted to distinguish MG‐specific electrochemical responses from background processes. Square‐wave voltammetry (SWV) of bare SPCE in the presence of MG and modified SPCEs in the absence of MG revealed a cathodic peak at near −0.9 V (Figure 1c,d), attributed to the oxygen reduction reaction (ORR). Supporting electrolytes (NaCl, KCl, MgCl2) enhance ORR currents by improving ionic conductivity and charge transport (Figure S2) [47]. Cyclic voltammetry (CV) further confirmed ORR contributions, with cathodic features observed near −0.2 and −0.9 V (Figure S3). In addition, the potential contribution of ORR was investigated by comparing the sensor's performance in aerated and N2‐purged electrolytes. The results showed N2 purging significantly enhanced peak sharpness and symmetry at low MG concentrations (< 1µM) by eliminating minor ORR‐related background currents observed near −1.1 V (Figure S4). At physiologically relevant concentrations (>5 µM), the faradaic current associated with MG reduction remains the dominant electrochemical response. Details of this experiment are provided in Section S5. Accordingly, cathodic signals occurring at or beyond −0.9 V were assigned to ORR rather than MG electrochemistry. Notably, AuNPs/fMWCNT‐modified electrodes exhibited substantially higher currents than bare SPCE under identical conditions (in presence of 0.1 M NaCl), underscoring enhanced electron transport and catalytic efficiency imparted by the nanocomposite architecture (Figure 1d,e). Comparative SWV responses of different electrode configurations in the presence of 5 µM MG (Figure 1e) further elucidate the role of material composition. The fMWCNT/SPCE showed a weak reduction peak current (−5.3 µA) near −0.82 V, attributable to hydrogen bonding and electrostatic interactions between MG and surface carboxyl groups [7]. In contrast, AuNPs/SPCE produced a substantially higher cathodic current (−30.4 µA) at around −0.75 V, reflecting the intrinsic electrocatalytic activity of AuNPs toward MG reduction. The AuNPs/fMWCNT/SPCE nanocomposite exhibited the highest reduction current (−60.8 µA) at a lower overpotential (−0.72 V), corresponding to a twofold enhancement over AuNPs/SPCE and more than an order of magnitude increase relative to fMWCNT/SPCE. This enhancement arises from synergistic coupling of AuNPs‐mediated electron transfer and fMWCNT‐enabled MG adsorption, which accelerates reduction kinetics while lowering the operating potential. The MG‐specific reduction peak at −0.72 V was consistently observed across varying MG concentrations (Figure 1f) and was clearly distinguishable from blank controls. CV further validated this assignment by differentiating MG‐related redox processes from ORR contributions (Figure S3). These results collectively demonstrate that material composition governs MG adsorption, electron‐transfer kinetics, and catalytic efficiency, establishing the AuNPs/fMWCNT nanocomposite as an effective electrode interface for sensitive MG detection. Electrodeposition and Electrocatalytic Effect of AuNPs/fMWCNT Nanocomposite The AuNPs/fMWCNT‐modified electrode was fabricated using a precisely controlled sequential electrodeposition strategy that directly links material growth to interfacial charge‐transfer kinetics and electroactive surface area. Unlike drop‐casting, electrodeposition enables binder‐free films with tunable thickness, uniform coverage, and strong substrate adhesion, which are essential for reproducible electrocatalytic performance. The sequential electrodeposition order of fMWCNT and AuNPs SPCE was evaluated to improve the sensitivity of the MG sensor. Two configurations were compared using 5 µM MG: (i) MWCNT/AuNPs (Au deposited first) and (ii) AuNPs/fMWCNT (fMWCNT deposited first). The AuNPs/fMWCNT electrode exhibited a higher current response of 82 µA, compared to 76 µA for the reverse configuration (Figure S5). This enhancement is attributed to the synergistic interaction between the conductive fMWCNT scaffold and the dendritic morphology of the electrodeposited gold. In the AuNPs/fMWCNT configuration, the fMWCNT layer provides a high‐surface‐area conductive framework and functional groups for MG capture. Subsequent gold electrodeposition promotes the formation of exposed dendritic gold structures on the outer sensing interface, improving electroactive site accessibility [42, 48]. In contrast, the lower current observed for the MWCNT/AuNPs configuration may arise from partial coverage of the underlying gold structures by the fMWCNT layer, which can reduce electroactive surface accessibility and increase interfacial resistance. Consequently, the AuNPs/fMWCNT architecture was selected for subsequent sensing studies. Optimization of the fMWCNT deposition potential was first performed to establish a stable conductive scaffold. SWV indicated that fMWCNT deposition is predominantly mass‐transport‐limited, as reflected by negligible current variation beyond a threshold potential. Based on deposition stability and film uniformity (Figure 2b), −1.2 V was selected as optimal, yielding a consistent CNT network without excessive aggregation, in agreement with previous reports [34]. In contrast, subsequent AuNPs growth exhibited strong potential dependence, consistent with nucleation–growth dynamics of metallic nanostructures. Relatively positive potentials (+0.1 to −0.3 V) favor non‐uniform, flower‐like Au morphologies, whereas more negative potentials promote denser and more uniform nanostructures [49]. Accordingly, AuNPs deposited at −0.6 V formed homogeneous surface coverage (Figure 2c), while more negative potentials induced overgrowth and morphological irregularities [50]. Electrochemical responses supported these observations, with peak current increasing from 27.74 µA at −0.2 V to 51.14 µA at −0.6 V, reflecting increased Au loading and electroactive surface area. Further shifting to −1.0 V reduced current and reproducibility, indicating unstable over‐deposition (Figure S6) [51]. SEM micrographs of (a) bare SPCE, (b) fMWCNT/SPCE, (c) AuNPs/fMWCNT/SPCE; AuNPs/fMWCNT/SPCE after Au deposition for (d) 180 s, (e) 300 s, and (f) 420 s. (g) High‐magnification (10 000×) image of leaf‐like Au nanostructures after 300 s deposition. (h) ATR‐FTIR spectra showing functional group evolution during sensor modification. After potential optimization, deposition time was varied to balance nanocomposite surface coverage with analyte accessibility. A duration of 300 s for both fMWCNT and AuNPs produced the maximum SWV current response (Figure S7). Extending deposition to 420 s caused a marked current decrease due to the formation of thick, densely packed layers that hinder analyte diffusion and partially block active sites, as confirmed by scanning electron microscopy (SEM) (Figure 2f) [52, 53]. In contrast, the optimized 300 s electrodeposition produces a nanocomposite consisting of cauliflower‐like Au nanoclusters and leaf‐like AuNPs uniformly embedded within a three‐dimensional (3D) tubular fMWCNT network (Figure 2e,g). Unlike conventional composites dominated by spherical morphologies with limited accessible surface area [25, 54], the sequential electrodeposition promotes direct electrochemical growth, yielding a textured interface with a high density of MG binding and catalytic sites. This architecture facilitates faster electron transfer and enhanced sensitivity relative to standard spherical nanoparticle‐based configurations. Energy‐dispersive X‐ray (EDX) analysis further confirms effective Au incorporation (Figure S8). Molecular‐level validation of the nanocomposite architecture was obtained using attenuated total reflectance Fourier‐transform infrared (ATR‐FTIR) spectroscopy. The fMWCNT‐modified electrode exhibited characteristic features associated with oxygen‐containing functional groups (Table S1), including a broad O–H stretching band (∼3400 cm−1), carbonyl C═O stretching vibrations (∼1700–1680 cm−1), and C–O stretching modes in the 1300–1000 cm−1 region, confirming successful surface functionalization [55, 56]. The graphitic C═C vibration appeared near 1600–1580 cm−1 [57]. Following AuNPs deposition, these bands persisted with subtle intensity changes and slight peak shifts, consistent with interactions between AuNPs and surface carboxyl groups and altered optical response from the metallic nanostructure. A sharp feature near ∼2300 cm−1 was assigned to atmospheric CO2 and identified as an instrumental artifact, as confirmed by control measurements and baseline correction (Figure 2h) [58]. The optimized AuNPs/fMWCNT nanocomposite exhibited markedly improved electronic performance, quantified by electrochemically active surface area (ECSA) and electrochemical impedance spectroscopy (EIS). The ECSA increased to 0.182 cm2 for AuNPs/fMWCNT/SPCE, compared with 0.0534 cm2 for bare SPCE, reflecting synergistic contributions from increased surface roughness and catalytic site density (Figure S9a and Table S3). EIS provided direct insight into interfacial charge‐transfer behavior. Nyquist plots revealed that bare SPCE exhibited a large semicircle corresponding to high charge‐transfer resistance (Rct ≈ 10 200 Ω), indicative of sluggish electron transfer. The fMWCNT/SPCE showed a similarly large Rct (≈9344 Ω), indicating that increased surface area alone does not ensure improved kinetics without effective electronic coupling. In contrast, the AuNPs/fMWCNT/SPCE displayed two much smaller semicircles with reduced Rct values of 27.85 and 77.32 Ω, highlighting the significant role of AuNPs in facilitating electron transfer (Figure S9 and Table S4). These results further confirm that the AuNPs/fMWCNT configuration provides the best electrochemical performance among the tested architectures, as the increase in ECSA coupled with the reduction in Rct is consistent with the superior current response. Equivalent circuit fitting supported this interpretation. While bare SPCE and fMWCNT/SPCE were modeled using a classical Randles circuit, the AuNPs/fMWCNT/SPCE required a more complex equivalent circuit to account for its layered interfacial structure. The validity of this fitting model was supported by the low chi‐squared (χ2) value of 0.0018 and minimal relative errors (all < 10%) for all circuit elements (Table S4), indicating an excellent agreement between the experimental data and the proposed multi‐component model [59]. The high‐frequency semicircle (Rct = 27.85 Ω) is attributed to rapid charge transfer at the AuNPs‐modified surface, whereas the low‐frequency semicircle (Rct = 77.32 Ω) reflects electron transport through the underlying fMWCNT network (Figures S9 and S11). A Warburg‐type diffusion tail at low frequencies further confirms diffusion‐controlled processes [60]. Collectively, these results show that sequential electrodeposition of AuNPs onto a functionalized CNT scaffold creates a hierarchical, electronically coupled interface that significantly enhances charge‐transfer efficiency and electrocatalytic performance, providing a robust foundation for sensitive MG detection. This sequentially electrodeposited AuNPs/fMWCNT/SPCE sensor exhibits the largest electroactive area (0.182 cm2) and lowest charge‐transfer resistance (27.85 Ω) among reported MG sensors, outperforming CS/MWCNT/GCE ( 0.0617 cm2) [34], PANI/NiO/GS ( 0.0131 cm2, 63.11 Ω) [26], and CuO/AuNPs/GCE (0.072 cm2, 353.20 Ω) [25]. The inferior performance of these systems is attributed to non‐uniform film morphology and insulating or semiconducting components that introduce diffusion barriers and hinder interfacial charge transport. This comparison confirms that the sequentially electrodeposited nanocomposite provides superior interfacial connectivity and a larger effective surface area relative to drop‐cast architectures, enhancing electrochemical performance. Quasi‐Reversible Kinetics and Mass Transport PCET Mechanism of MG MG exhibits pronounced material‐dependent redox behavior, with operating potentials and dominant products varying across electrode surfaces. Metal oxides such as V2O5 and CuO have been reported to favor oxidation pathways leading to pyruvate [35, 61], whereas conductive polymers and carbon‐based materials (including PANI, SWCNTs, MWCNTs, and functionalized MWCNTs) more commonly promote reduction pathways yielding hydroxyacetone [26, 32, 33, 34]. In some systems, concurrent oxidation and reduction processes have been observed [32, 33, 34, 35], highlighting the complexity of MG interfacial electrochemistry. The electrochemical behavior of MG at the AuNPs/fMWCNT‐modified electrode was investigated to elucidate its quasi‐reversible nature, focusing on the interplay between mass transport and proton‐coupled electron transfer (PCET). Understanding these dynamics is essential, as quasi‐reversibility governs electron‐transfer efficiency, mass‐transport, and signal stability in electrochemical sensing. Mass Transport and Interfacial Kinetics To investigate the mass‐transfer and kinetic behavior of MG, cyclic voltammograms were recorded at scan rates ranging from 10 to 100 mV s−1 in 1 µM MG prepared in 0.1 M NaCl (Figure 3b). A well‐defined cathodic peak associated with MG reduction was consistently observed between −0.7 and −0.8 V, accompanied by a broad anodic response and a weaker secondary anodic peak at more positive potentials. (a) Linear correlation of logarithm based cathodic peak current (Ip) with scan rate (v); (b) CVs of 1 µM MG at scan rates of 10–100 mV·s−1, showing increased cathodic current and negative peak potential shifts, consistent with a quasi‐reversible redox behavior; (c) LSV responses of 10 µM MG at pH 5–9 (scan rate 50 mV·s−1); (d) Dependence of Ip and peak potential (Ep ) on pH, showing maximal current at pH 7 and a linear Ep shift consistent with a 2e−/2H+ PCET mechanism. As the scan rate increased, the cathodic peak current (Ip ) increased proportionally, while the cathodic peak potential shifted toward more negative values and the peak‐to‐peak separation (ΔEp ) broadened. This behavior is characteristic of kinetically limited electron transfer, where interfacial equilibrium cannot be fully maintained at higher scan rates. The observed peak separation (ΔEp ≈ 70 mV) further confirms a quasi‐reversible electrode process. To quantitatively assess the electron‐transfer kinetics, the standard heterogeneous rate constant (k 0) was estimated using the Nicholson method, yielding a value of k 0 = 2.5 × 10−2 cm s−1 [62]. This magnitude is consistent with quasi‐reversible electron‐transfer kinetics and the scan‐rate‐dependent voltammetric behavior observed for MG reduction [63, 64]. The dominant mass‐transport mechanism was evaluated using the power‐law relationship Ip = aνb [65]. A unified linear regression of log Ip vs. log of scan rate (log ν) across the full scan‐rate range yielded the equation: (1) logIp=0.6019logv+0.5986R2=0.9966 The slope of 0.6019 (Figure 3a) indicates that MG reduction at the AuNPs/fMWCNT/SPCE interface follows mixed diffusion‐adsorption kinetics with diffusion as the dominant contribution. This behavior arises because increasing scan rate reduces bulk diffusion contributions while increasing the relative contribution of pre‐adsorbed MG species (Figure S12). Proton‐Coupled Electron Transfer (PCET) Mechanism The influence of solution pH on MG electrochemistry was examined to probe the role of proton‐coupled electron transfer. Linear sweep voltammetry (LSV) was conducted using 10 µM MG over a pH range of 5–9 at a fixed scan rate of 50 mV s−1 (Figure 3c). The cathodic peak current increased with pH, reached a maximum at pH 7, and decreased at higher pH values (Figure 3d). This behavior is attributed to optimal proton availability at neutral pH, which facilitates efficient PCET during MG reduction [34]. At pH values above 7, reduced proton concentration limits proton participation in the redox process, resulting in diminished current response. In addition, the cathodic peak potential (Ep ) shifted progressively toward more negative values with increasing pH (Figure 3c,d), indicating the involvement of a proton‐coupled electron transfer process. Under proton‐deficient conditions, the redox reaction becomes thermodynamically less favorable, requiring higher overpotentials. A linear relationship between Ep and pH was observed, described by: (2) EpV=−0.0515pH−0.4615R2=0.9996 The slope of −51.5 mV pH−1 is close to the theoretical Nernstian value (≈ −59 mV pH−1 at 298 K), suggesting that an equal number of protons (m) and electrons (n) participate in the redox process (m/n ≈ 1). To estimate the number of electrons involved, the electron transfer kinetics were further analyzed using Laviron's treatment of kinetically limited electron‐transfer systems [66]. A linear relationship between the cathodic peak potential and the logarithm of the scan‐rate (log ν) was obtained (Figure S14): (3) Ep=−0.0584logv−0.6672R2=0.9966 According to Laviron's equation, the slope of this plot is given by − 2.303RT/(αnF) [66]. Assuming a temperature of 298 K and a charge transfer coefficient (α) of 0.5, the number of transferred electrons was estimated to be approximately n ≈ 2. Combined with the pH‐dependent analysis, these results are consistent with a two‐electron, two‐proton coupled transfer mechanism. Collectively, while scan rate studies confirm that MG undergoes quasi‐reversible electrochemical reduction at the AuNPs/fMWCNT/SPCE interface through a dynamic interplay of diffusion and kinetic control, pH‐dependent analyses confirm a proton‐coupled electron transfer mechanism. This mechanistic insight enables improved control over mass transport, electron‐transfer kinetics, and operational stability under conditions relevant to non‐invasive biofluid analysis. Concentration Dependent SWV Analysis To evaluate the analytical performance of the AuNPs/fMWCNT/SPCE sensor and probe concentration‐dependent MG reduction kinetics, SWV was employed for its high sensitivity and suppression of non‐Faradaic currents [16, 67]. In SWV, square‐wave modulation is superimposed on a staircase waveform, enhancing Faradaic responses and enabling trace‐level detection. Using the optimized electrode, MG responses were investigated over a wide concentration range of 50 nM–100 µM (Figure 4). Electrochemical determination and calibration curve of the sensor toward the target analyte. (a) SWV response for increasing concentrations of the target analyte (Blank to 100 µM; inset highlights low concentrations). (b) Two‐segment linear calibration curve showing the relationship between current response and concentration with corresponding sensitivities. Across this range, a well‐defined reduction peak consistently appeared at approximately −0.72 V, corresponding to reduction of the aldehyde group of MG. Increasing MG concentration produced proportional increases in Ip , confirming efficient electron transfer at the AuNPs/fMWCNT‐modified surface. The calibration behavior exhibited two distinct linear regimes, indicating a transition in dominant mass‐transport and surface‐interaction mechanisms. In the low‐concentration regime (50 nM–10 µM), the sensor displayed a steep linear current response with a regression equation: (4) IMG=14.457CMG+10.048R2=0.991 yielding an LOD of 40 nM (Figure 4a,b). High sensitivity in this range is attributed to efficient diffusion of MG from the bulk solution to abundant active sites, enabling rapid reduction without surface saturation. Mass transport is therefore diffusion‐controlled, governed primarily by concentration gradients, consistent with Fickian behavior [68]. This concentration window encompasses physiologically relevant MG levels reported in human serum and saliva for both healthy and diabetic individuals, underscoring the clinical relevance of the sensor's high‐sensitivity regime. At higher MG concentrations (10–100 µM), the response transitioned to a second linear regime with reduced slope, described by (Figure 4a,b): (5) IMG=1.55CMG+136R2=0.9952 defining an extended linear quantification range, beyond MG physiological levels with diabetes patients. In this regime, MG flux to the electrode surface approaches or exceeds the rate of electrochemically reduction, leading to partial saturation of available catalytic sites. Consequently, the formation of a diffusion‐depleted layer near the electrode interface limits mass transport, rendering diffusion the rate‐determining step. This behavior is consistent with Warburg‐type diffusion features observed in EIS at low frequencies [69]. Despite reduced sensitivity at elevated concentrations, the electrode maintained a stable, quantifiable response across the entire range, demonstrating its robustness and a broad dynamic window. The two linear regions reflect the quasi‐reversible, mixed diffusion–adsorption kinetics established in Section 2.3, further validating the mechanistic framework of MG electroreduction at the AuNPs/fMWCNT interface. Overall, the AuNPs/fMWCNT/SPCE sensor combines low detection limits, high sensitivity within clinically relevant concentration ranges, and broad dynamic operation. Comparison with previously reported non‐enzymatic MG sensors (Table S4) highlights superior sensitivity and practical suitability, particularly for sub‐micromolar MG detection relevant to non‐invasive biomedical monitoring. Selectivity, Reproducibility, Repeatability and Stability Analysis The practical applicability of the AuNPs/fMWCNT/SPCE sensor for MG detection was evaluated through selectivity, reproducibility, repeatability, and long‐term stability analyses, assessing analytical reliability under conditions relevant to PoC diagnostics. Selectivity was evaluated in deionized water (DIW) using SWV in the presence of common biological interferents, including glucose, urea, and other electroactive species at concentrations 100‐fold higher than MG (500 µM interferents vs. 5 µM MG) (Figure 6a). The combined interferent solution without MG exhibited no reduction signal within the MG detection window. A weak cathodic response was observed beyond −1.1 V, consistent with dissolved oxygen reduction. Importantly, no overlapping or interfering redox peaks were detected near the MG reduction potential. Comparison of the MG‐only response with mixed solutions containing both MG and interferents revealed only a slight cathodic shift in peak potential together with minor peak broadening and current attenuation. These effects are likely attributable to nonspecific adsorption of interfering species on the electrode surface, resulting in partial interfacial fouling and hindered mass transport that moderately influence local electron‐transfer kinetics and diffusion pathways. Nevertheless, the MG reduction peak remained clearly distinguishable without overlapping signals, confirming that the sensor response predominantly originates from the catalytic reduction of MG at the AuNPs/fMWCNT/SPCE interface. This selectivity arises from electrochemical discrimination rather than chemical masking: most biological interferents oxidize at positive potentials (typically +0.2 to +0.6 V vs. Ag/AgCl) due to electron donation from hydroxyl, amine, or thiol functionalities, whereas MG undergoes reduction at negative potentials (approximately −0.7 to −0.8 V vs. Ag/AgCl) [34, 70]. In addition, structurally similar carbonyl and dicarbonyl species relevant to saliva and sweat—namely glyoxal, 3‐deoxyglucosone (3‐DG), and hydroxyacetone—were evaluated to assess selectivity against closely related metabolites (Figure S20A). Both 3‐DG and hydroxyacetone exhibited no detectable redox activity within the investigated potential window, indicating negligible electrochemical interference in the MG sensing region. Glyoxal, while electroactive, displayed a weak reduction response only at substantially more negative potentials (< −1.00 V vs. Ag/AgCl), well outside the MG sensing region. Reproducibility was evaluated using six independently fabricated AuNPs/fMWCNT/SPCE sensing electrodes (E01–E06), each tested with 1 µM MG under identical experimental conditions. The cathodic peak currents exhibited a relative standard deviation (RSD) of 3.64% (Figure 5a), indicating excellent batch‐to‐batch consistency and reproducible fabrication. SWV responses and peak current variations of AuNPs/fMWCNT/SPCE: (a) reproducibility across six independently fabricated electrodes (E01–E06); (b) repeatability over five consecutive measurements using a single electrode; and (c) long‐term stability over 36 days with measurements at 7‐day intervals. Repeatability was assessed through five consecutive measurements of 1 µM MG using a single electrode without surface regeneration. The resulting RSD of 1.9% (Figure 5b) demonstrates high short‐term precision and minimal signal drift during repeated measurements, highlighting the robustness of the electrode interface under continuous operation. Long‐term stability was evaluated over 36 days to assess signal retention under storage conditions relevant to PoC deployment. Sensors stored at room temperature (25 ± 1°C) under ambient light in sealed Petri dishes to limit environmental exposure. Measurements conducted at 7‐day intervals using 5 µM MG revealed that the sensor retained 95.21% of its initial current response after 36 days, with an RSD of 3.6% (Figure 5c), indicating minimal performance degradation over time. Collectively, these results demonstrate that the AuNPs/fMWCNT/SPCE sensor exhibits strong selectivity, excellent reproducibility and repeatability, and robust long‐term stability. These attributes arise from the stable, binder‐free nanocomposite architecture and the inherent separation of MG reduction from common biological redox processes. Such analytical robustness is essential for reliable, interference‐free MG detection and supports the suitability of the platform for portable and clinically relevant PoC applications. Microfluidic Device‐Based MG Detection in Saliva and Sweat To evaluate the translational feasibility for non‐invasive PoC applications, the AuNPs/fMWCNT/SPCE sensor was tested in complex biological matrices—human saliva, sweat, and artificial sweat—using the integrated microfluidic platform (Figures S17–S19). This configuration enables controlled sample handling, reduced reagent use, and isolation of biological fluids from the sensing interface, which are essential for decentralized diagnostics. Initial measurements without a supporting electrolyte resulted in weak, unstable, or undetectable signals, reflecting the high internal resistance and variable ionic composition of saliva and sweat. This confirms that reliable electrochemical transduction in these matrices requires an external ion source to facilitate charge transport. Accordingly, subsequent measurements were conducted by simultaneously introducing 75 µL of clarified biological sample and 75 µL of 0.1 M NaCl supporting electrolyte through separate microchannels, ensuring consistent ionic strength and stable electrochemical conditions (Video S1). Detailed protocols for human subject recruitment, biofluid collection, and metabolite extraction are provided in the supplementary information (Section S4). Saliva Analysis SWV measurements enabled reliable detection of spiked MG concentrations ranging from 50 nM to 5 µM in human saliva (Figure 6b). This range encompasses reported physiological MG concentrations in healthy individuals (0.19–0.26 µM) and diabetic patients (1.32–1.42 µM) [26]. Quantitative analysis yielded an average recovery of ∼97% across all tested concentrations (Table 1), demonstrating excellent analytical accuracy in this complex biological matrix. SWV response of AuNPs/fMWCNT/SPCE sensor in (a) DIW against common interferents (100‐fold excess) compared with solution combining 5 µM MG and all interferents, (b) human saliva and (c) artificial sweat spiked with varying concentration of MG and 0.1M NaCl. (d) Calibration curve of MG detection in artificial sweat demonstrating linearity and sensitivity in the tested ranges. TABLE 1Validation of accuracy and precision through spiking and recovery tests of MG in human saliva.SampleMG Added (µM)Found (µM)Recovery (%)1—Not detected—0.050.04997.090.10.09696.410.50.43787.3711.012101.1554.79795.942—Not detected—0.050.04692.230.10.102102.170.50.47895.6410.94994.9254.55191.023—Not detected—0.050.04895.150.10.10099.910.50.49398.6411.053105.2755.105102.09John Wiley & Sons, Ltd. Validation of accuracy and precision through spiking and recovery tests of MG in human saliva. A consistent cathodic peak shift to more negative potentials (e.g., from −0.73 V in aqueous electrolyte to ∼−0.88 V in saliva) was observed. This shift arises from saliva matrix effects, including protein content, variable ionic strength, and local pH fluctuations, which slow heterogeneous electron‐transfer kinetics and increase overpotential [71, 72]. In addition, nonspecific adsorption of salivary macromolecules—particularly high‐molecular‐weight glycoproteins such as mucins—can partially foul the electrode surface and hinder analyte access to active sites [71, 72]. Despite these effects, the sensor maintained clear, quantifiable MG signals, highlighting the robustness of the AuNPs/fMWCNT nanocomposite interface. Sweat Analysis The sensor performance was further evaluated in artificial and real sweat samples to assess suitability for wearable and epidermal sensing. For artificial sweat, SWV measurements revealed a characteristic MG reduction peak at ∼−0.76 V, slightly shifted from that observed in DIW (−0.73 V) (Figure 6c). This modest negative shift is attributed to matrix‐induced changes in ionic composition and electrochemical kinetics within the sweat environment. Despite this shift, the sensor exhibited excellent analytical performance, displaying two linear response regimes: a high‐sensitivity low‐concentration range of 50 nM–10 µM with a limit of detection of 0.4 µM (Figure 6d), and an extended linear quantification range of 10–50 µM characterized by a reduced calibration slope (Figure S13). Calibration curves obtained in artificial sweat closely matched those recorded in DIW (Section 2.5) [34, 70], with comparable peak currents and an average recovery of 98.35% (Table S5). Importantly, the lower detection range fully encompasses clinically reported MG concentrations in sweat (>0.78 µM), underscoring the relevance of the platform for non‐invasive metabolic monitoring [73]. As for real sweat analysis, evaluation across three independent human sweat samples demonstrated that the optimized sensor enabled reliable MG quantification over the concentration range of 0.1–10 µM, with near‐quantitative recoveries (∼98–104%) and low relative standard deviations (RSDs <5%), supporting its suitability for spiked real‐sample analysis (Table 2). TABLE 2Analytical performance and spike‐recovery analysis of the AuNPs/fMWCNT/SPCE sensor for MG detection in three independent real human sweat samples.Sweat SampleAdded MG (µM)Found MG (µM) (Mean ± SD)Recovery (%)RSD (n = 3)1—Not detected——0.1 (100 nM)0.104 ± 0.003104.20%3.15%0.5 (500 nM)0.512 ± 0.015102.40%2.91%10.985 ± 0.02198.50%2.14%1010.15 ± 0.28101.50%2.76%2—Not detected——0.1 (100 nM)0.098 ± 0.00498.10%4.08%0.5 (500 nM)0.495 ± 0.01899.00%3.64%11.031 ± 0.035103.10%3.39%109.82 ± 0.3198.20%3.16%3—Not detected——0.1 (100 nM)0.101 ± 0.002101.00%1.98%0.5 (500 nM)0.508 ± 0.012101.60%2.36%10.992 ± 0.01999.20%1.92%1010.08 ± 0.22100.80%2.18%John Wiley & Sons, Ltd. Analytical performance and spike‐recovery analysis of the AuNPs/fMWCNT/SPCE sensor for MG detection in three independent real human sweat samples. pH Dependency, Reproducibility, and Operational Stability in Sweat and Saliva The analytical performance of the AuNPs/fMWCNT/SPCE platform was comprehensively validated through pH‐dependency, reproducibility, and operational stability studies in real saliva and sweat (Supplementary Information S6–S8). The platform demonstrated higher recovery and improved signal retention in sweat, likely due to the lower concentration of protein interferents (such as mucin) and the resulting reduction in biofouling effects compared to the saliva matrix. The sensor in buffer exhibited a systematic cathodic shift toward more negative potentials with increasing pH and achieved optimal sensitivity at pH 7.0, supporting accurate quantification across the physiological pH ranges of both biofluids (Figure S15). Manufacturing consistency was confirmed through batch‐to‐batch reproducibility studies across three independent fabrication cycles, yielding low relative standard deviation (RSD) values ranging from 1.74% to 6.18% (Table S6). In addition, the platform maintained operational stability under repeated measurements (Table S7). Repeated SWV scans without cleaning led to signal attenuation, with peak currents retaining 66.2% in saliva and 61.6% in sweat due to localized analyte depletion and progressive fouling from biomolecule adsorption (Figure S16a). During extended operation, the sensor retained 69.4% of the signal in saliva and 79.2% in sweat after 30 min (Figure S16b). These performance variations are attributed to analyte depletion and matrix‐specific protein fouling effects. Collectively, these results demonstrate that the integrated microfluidic AuNPs/fMWCNT/SPCE sensor provides clinically relevant sensitivity, high recovery, and robust performance in both saliva and sweat despite matrix effects. Accurate MG detection in non‐invasively accessible biofluids supports the platform's potential for portable PoC diagnostics and future wearable diabetes monitoring. Clinical Implications and Outlook The translational relevance of the proposed AuNPs/fMWCNT/SPCE platform is supported by its low‐cost fabrication and compatibility with scalable manufacturing approaches. By utilizing screen‐printed electrodes as the base substrate (≈3.00 CAD per unit) and a 3D‐printed microfluidic housing (≈0.94 CAD in material costs), the total material cost per device is estimated to be approximately 3.94 CAD (Table S8). The use of gold nanoparticles—often a significant cost driver—is minimized through a controlled electrodeposition process requiring only 0.5 mg of gold precursor per sensor. Moreover, the entire fabrication workflow, from nanohybrid modification to microfluidic assembly, is conducted in a standard laboratory environment without the need for expensive cleanroom facilities or photolithographic processes. This cleanroom‐free approach, combined with additive manufacturing techniques, supports scalable and cost‐effective fabrication in resource‐limited settings, positioning the platform as a promising candidate for future non‐invasive diabetes monitoring applications. The demonstrated analytical performance of the AuNPs/fMWCNT/SPCE platform—characterized by high sensitivity, selectivity, and robustness in non‐invasive biofluids—provides a strong foundation for translation toward clinically relevant point‐of‐care (PoC) diabetes monitoring. Beyond proof‐of‐concept sensing, a key challenge lies in integration into portable, autonomous systems capable of reliable real‐world operation while meeting clinical validation requirements. Translation Toward Portable and Autonomous PoC Diagnostics The current 3D‐printed PDMS microfluidic system serves as an effective benchtop prototype for controlled sample handling and non‐invasive MG detection; however, translation to a deployable PoC format requires further miniaturization and mechanical adaptation. Future work will focus on transferring the AuNPs/fMWCNT/SPCE architecture onto flexible polymer substrates such as polyimide (Kapton) or polyethylene terephthalate, which offer mechanical durability, chemical stability, and compatibility with wearable form factors [74, 75]. Integration of miniaturized PDMS microchannels onto these flexible substrates will enable conformal skin contact while preserving precise fluid control and sample–electrode interactions. To achieve autonomous operation, the platform will be coupled with a compact, low‐power potentiostat implemented via application‐specific integrated circuit (ASIC) design, enabling on‐board signal amplification, noise reduction, and data processing without bulky external instrumentation. In parallel, incorporation of low‐energy wireless communication modules (e.g., Bluetooth Low Energy or near‐field communication) will facilitate real‐time data transmission for continuous monitoring, data storage, and remote analysis [76, 77]. Collectively, these system‐level advancements outline a practical pathway toward portable, non‐invasive PoC devices for real‐time MG monitoring beyond conventional clinical settings. Clinical Validation and Environmental Robustness While the present study demonstrates sensitive and selective electrochemical detection of MG in sweat and saliva matrices, all biofluid experiments were conducted using externally spiked samples. Although this approach is widely accepted for proof‐of‐concept validation, it does not directly confirm the detection of endogenous MG under in vivo conditions. In physiological environments, MG may exist partially in protein‐bound forms, as hydrated species, or in equilibrium with chemically modified adducts, which could influence its electrochemical availability and apparent concentration at the electrode interface. Accordingly, the current results should be interpreted as evidence of analytical capability and biofluid compatibility rather than definitive quantification of endogenous MG in clinical contexts. Translation toward non‐invasive diabetes monitoring will require further studies involving minimally processed human samples, correlation with established analytical methods, and evaluation of MG speciation and binding effects in vivo [78]. Nevertheless, the demonstrated nanomolar‐level sensitivity, high selectivity, and consistent electrochemical performance in sweat and saliva provide a promising foundation for future clinical validation and the development of PoC MG monitoring tools. In parallel, systematic evaluation of environmental robustness is required to ensure reliable sensor operation during unsupervised, real‐world use. This includes assessing the effects of temperature fluctuations, humidity, ambient light, and mechanical deformation on electrochemical performance, signal stability, and device longevity. Addressing these factors is essential for successfully transitioning the platform from controlled laboratory environments to practical PoC and wearable applications [79]. Future integration of machine learning‐assisted signal correction approaches may further improve compensation for pH‐dependent peak shifts, matrix effects, and signal drift [80]. Such data‐driven approaches offer a promising future pathway to enhance analytical accuracy, robustness, and real‐world applicability of non‐invasive MG monitoring systems. In summary, the AuNPs/fMWCNT/SPCE platform represents a promising step toward non‐invasive MG monitoring for diabetes management. Continued development focused on device integration, clinical validation, and environmental robustness may enable advances in personalized metabolic monitoring and next‐generation PoC diagnostic systems. Conclusion In this work, we report an engineered gold–carbon nanohybrid electrochemical platform for sensitive and selective detection of MG, a clinically relevant biomarker of diabetes progression. The sensor was fabricated by sequential electrodeposition of fMWCNT and AuNPs onto a SPCE and integrated into a custom 3D‐printed PDMS microfluidic device. This hybrid architecture synergistically enhances sensing performance: fMWCNT provide a conductive scaffold with surface carboxyl groups that promote MG preconcentration through hydrogen‐bonding and dipole–dipole interactions, while AuNPs increase electroactive surface area and facilitate electrocatalytic reduction through favorable surface electronic properties. As a result, the electroactive surface area increased from 0.0534 to 0.182 cm2, while the charge‐transfer resistance decreased from 9344 to 27.85 Ω, enabling efficient MG electroreduction. Electrochemical investigations show that MG undergoes quasi‐reversible redox behavior at the AuNPs/fMWCNT/SPCE interface through a two‐electron PCET mechanism, with optimal performance at physiological pH (pH 7). Scan‐rate‐ and pH‐dependent analyses indicate mixed diffusion‐adsorption‐controlled kinetics, reflecting MG adsorption on fMWCNT and enhanced electron transfer at AuNPs sites. Optimization of electrodeposition conditions—300 s deposition at −1.2 V for fMWCNT and −0.6 V for AuNPs—was essential to produce uniform, binder‐free nanocomposite films while avoiding excessive growth that limits mass transport and catalytic accessibility. The optimized platform exhibits strong analytical robustness, including high repeatability (RSD 1.9%), reproducibility (RSD 3.64%), and stability over 36 days, which are attributed to the mechanically stable nanocomposite formed by sequential electrodeposition. The sensor also shows high selectivity due to its distinct cathodic detection potential and achieves ∼97% recovery in human saliva and artificial sweat, confirming applicability in complex biological matrices. Overall, this study establishes a mechanistically informed and promising electrochemical platform for non‐invasive MG monitoring. Integration of hybrid nanomaterials with microfluidic control provides a foundation for future development of portable and wearable POC devices with potential applications in personalized diabetes management and real‐time metabolic monitoring. Experimental Materials and Reagents, Preparation of Electrode and Electrochemical Measurements and Characterizations Details of materials and reagents, preparation of electrode and electrochemical measurements and characterizations are explained in the (Sections S1–S3). Microfluidic Device Fabrication The sensing platform consists of a manually assembled, layered microfluidic device secured using M3 screws and nuts. The device comprises four functional layers: (i) a 3D‐printed polylactic acid (PLA) backplate, (ii) the SPCE, (iii) a two‐layer PDMS microfluidic structure, and (iv) a 3D‐printed front cover with an integrated mounting washer to ensure leak‐free sealing (Figure S17 and S18). All structural components were designed in Autodesk Inventor and fabricated using a Prusa MK4 3D printer, with each layer having external dimensions of 53 mm × 33 mm × 3 mm. The PDMS layers were prepared using a standard 10:1 elastomer‐to‐curing‐agent ratio, degassed, cast into 3D‐printed molds, and cured at 65°C for 2 h. The microfluidic architecture features a main channel connected to a circular sensing chamber (8 mm diameter) positioned directly above the SPCE working electrode. A dual‐inlet configuration with two channels angled at 45° enables simultaneous and independent delivery of the biological sample and supporting electrolyte to the sensing region. This design is critical for measurements in high resistance biofluids, such as saliva and sweat, where immediate introduction of a conductive electrolyte is required to stabilize the electrochemical interface and ensure reliable signal transduction. An outlet located at the base of the microfluidic structure allows trapped air to escape during filling, preventing bubble formation that could disrupt fluid flow and introduce impedance artifacts. This configuration ensures complete filling of the sensing chamber and uniform analyte–electrolyte contact at the electrode surface. An extended contact pad integrated into the backplate facilitates straightforward electrical connection to the potentiostat. The integrated microfluidic platform operates under a strictly laminar flow regime (Re = 10.67) (detailed calculation provided in Section S9), as verified by the channel dimensions (w = 1 mm, h = 2 mm) and an average flow velocity of 0.008 m/s. Under these conditions, fluid motion remains orderly and free of turbulence, minimizing fluctuations associated with manual pipette loading and facilitating rapid stabilization of in‐channel dynamics [81, 82]. Designed for pump‐free, passive delivery, the device utilizes a dual‐channel mixing system where 80 µL of MG sample and NaCl electrolyte are introduced sequentially to achieve an effective 1:1 volume ratio. The precision of this dual‐channel loading and the resulting in situ mixing were visually validated using colored dye solutions, as demonstrated in Video S2. This configuration establishes a stable co‐flowing interface where mixing occurs predominantly via molecular diffusion at the electrochemical sensing region. This diffusion‐based process promotes reproducible analyte delivery to the AuNPs/fMWCNT/SPCE electrode while minimizing flow‐induced variability. The modularity of the design allows for easy disassembly and rinsing with DIW for reusability, providing a robust and practical framework for electrochemical detection in complex biological matrices like saliva and sweat. Author Contributions Ahadul Amin Soshi: Writing – review & editing, Writing – original draft, Visualization, Validation, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Md Younus Ali: Writing – review & editing, Visualization, Validation, Methodology, Conceptualization. Dadbeh Pazuki: Writing – review & editing, Visualization, Validation, Methodology, Conceptualization. Matiar M․R Howlader: Writing – review & editing, Writing – original draft, Validation, Supervision, Resources, Project administration, Funding acquisition, Conceptualization. Funding This research is supported by a Discovery Grant from the Natural Science and Engineering Research Council (NSERC) of Canada (RGPIN‐2024‐06809), the McMaster University Faculty of Engineering Doctoral Scholarship for Multi‐Disciplinary Research Award, and a McMaster Start‐up Grant. Our gratitude extends to the Labarge Center for Mobility in Aging within the McMaster Institute for Research on Aging and The Michael G. DeGroote Institute for Pain Research and Care for the Catalyst Grant Funding. Ethics Statement The study involved a limited number of participants and employed a non‐invasive biofluid collection protocol (sweat and saliva). In accordance with institutional guidelines, formal ethics committee approval was not required. Nevertheless, all participants provided written informed consent prior to sample collection. All data were fully anonymized to protect participant confidentiality, and the study was conducted in accordance with the principles of the Declaration of Helsinki on biomedical research involving human subjects. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting File 1: adhm71368‐sup‐0001‐SuppMat.pdf. Supporting File 2: adhm71368‐sup‐0002‐VideoS1.mp4. Supporting File 3: adhm71368‐sup‐0003‐VideoS2.mp4.